BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference

  September 3, 2024

   · 

  1 min read
• Business

  Nkarta to Participate in Upcoming Investor Conference

  September 3, 2024

   · 

  1 min read
• Business

  Labcorp to Speak at the Baird 2024 Global Healthcare Conference

  September 3, 2024

   · 

  1 min read
• FDA

  Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

  September 3, 2024

   · 

  5 min read
• Drug Development

  Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety

  September 3, 2024

   · 

  5 min read
• FDA

  Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma

  September 3, 2024

   · 

  7 min read
• Press Releases

  Numerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024

  Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued excitement for our BETonMACE program, which observed a non-prespecified 63% reduction in MACE and heart failure hazard among patients taking next-generation glucose lowering drugs

  September 3, 2024

   · 

  6 min read
• Business

  Codexis to Participate in Upcoming Healthcare Conferences

  September 3, 2024

   · 

  1 min read
• Business

  Iovance Biotherapeutics to Present at Upcoming Conferences

  September 3, 2024

   · 

  6 min read
• Business

  Ascendis Pharma Reports Second Quarter 2024 Financial Results

  September 3, 2024

   · 

  14 min read